Apellis Pharmaceuticals, Inc. (APLS)

40.90 -0.04 (-0.09%) USD  |  NASDAQ  |  Apr 22, 10:43
More

Apellis Pharmaceuticals Hold Recommendations

Hold Recommendations Chart

View Hold Recommendations for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Hold Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Hold Recommendations Range, Past 5 Years

View Hold Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Hold Recommendations Benchmarks

View Hold Recommendations Benchmarks
Start Trial
Biogen, Inc. Upgrade
Eli Lilly & Co. Upgrade
Agios Pharmaceuticals, Inc. Upgrade
Scholar Rock Holding Corp. Upgrade
Kezar Life Sciences, Inc. Upgrade